Innovation Award

Innovation Award from the GDCh Division of Medicinal Chemistry

The Medical/Pharmaceutical Chemistry Innovation Award is awarded by the Division of Medicinal Chemistry of the German Chemical Society (GDCh) together with the Pharmaceutical/Medical Chemistry Division of the German Pharmaceutical Society (DPhG). The prize honors outstanding scientific publications and results in the fields of medicinal and pharmaceutical chemistry. The award comes with a certificate of award and prize money of 5,000 euros donated by the two Divisions . The award usually takes place annually as part of the “Frontiers in Medicinal Chemistry” Conference . The price can be shared.

Current call for proposals: Innovation Award for Medical/Pharmaceutical Chemistry 2025

Deadline: 31 October 2024

Objective
Every year, the GDCh Division of Medicinal Chemistry and the DPhG Division for Pharmaceutical/Medical Chemistry jointly award this prize to recognize outstanding and independent scientific research in medical and pharmaceutical chemistry – as demonstrated by publications in scientific journals.

The price
The award comes with a certificate and prize money of 5,000 euros donated by the two Divisions . The prize can be shared. The prize will be awarded during the Conference "Frontiers in Medicinal Chemistry", which will take place in Erlangen from April 1 to 4, 2025. The awardee winner will be invited to present their own research area in a short lecture during the Conference . The costs for attending the conference will be borne by the Division. The award will be decided by a prize committee appointed by the two Divisions boards; each Division will appoint two members.

Nomination/Application
Nominations and applications are possible. Candidates should have completed their doctorate no more than ten years ago. Publications published between 2020 and 2024 will be considered. Each application/nomination contains the following information:

     

  • concise justification (max. 1 page),
  • CV (including contact details),
  • Report from a mentor,
  • Overview of independent postdoctoral activities with regard to habilitation or equivalent qualifications and
  • electronic reprints of the publications.

submission
Please send your proposal by email and summarized in a PDF file to the GDCh Office for the attention of Maike Fries.

Innovation Award for Medical/Pharmaceutical Chemistry 2024

v.li.n.re.: Prof. Dr. Christian Ducho,
Dr. Thanigaimalai Pillaiyar und
Dr. Christian Kuttruff
Foto: Dr. Jörg Pabel, München

The Innovation Award 2024 was presented on 19 March 2024 at the Division conference "Frontiers in Medicinal Chemistry 2024" in Munich to
Dr. Thanigaimalai Pillaiyar was awarded "in recognition of his outstanding, original and pioneering research work. Mr. Pillaiyar has made considerable scientific contributions to the medicinal chemistry of antiviral therapeutics, particularly for substances with activity against coronaviruses. Particularly innovative is the addressing of viral and host kinases to develop antiviral compounds with a broad spectrum of activity. This opens up new approaches to combating dengue, Zika and influenza viruses. The scientific success of his innovative work is impressively documented by publications in the highest international journals."

Innovation Award for Medical/Pharmaceutical Chemistry 2023

v.li.n.re.: Christian Ducho,
Matthias Schiedel, Christian Kuttruff

The Innovation Award 2023 was presented on April 4, 2023, at the Division conference "Frontiers in Medicinal Chemistry 2023" in Vienna to
Dr. Matthias Schiedel   awarded "in recognition of his outstanding, original and pioneering research work. By addressing intracellular allosteric binding sites of G protein-coupled receptors, Dr. Schiedel was able to develop novel concepts for controlling receptor selectivity and functional selectivity. By applying PROTAC strategies, GPCRs could be targeted for proteasomal degradation. The scientific success of his innovative and independent work is impressively documented by publications in high-ranking international journals."

Innovation Award for Medical/Pharmaceutical Chemistry 2022

Steffen Pockes
Oliver Thorn-Seshold

The Innovation Award was presented to Dr. on March 15, 2022 on the occasion of the Online FiMC 2022. Steffen Pockes and Dr. Awarded to Oliver Thorn-Seshold.

Dr. Pockes: "in recognition of his excellent, original and pioneering research work. Dr. Pockes' scientific work deals with the development of novel active ingredients to combat neurodegenerative diseases. The focus is on innovative ligands for G protein-coupled receptors and selective caspase inhibitors . The scientific success of his innovative and independent research work is documented by publications in the highest-ranking journals in medicinal chemistry."

Dr. Thorn-Seshold: "in recognition of his outstanding, original and pioneering research work. Dr. Thorn-Seshold is developing structurally chemically novel, photoswitchable modulators of the cytoskeleton. This work ranges from basic research to application in vivo. New strategies are being developed with photoswitchable antimitotics and vascular-damaging agents for tumor therapy. The scientific success of his innovative and independent work is documented by publications in the highest-ranking international journals and by considerable acquisition of third-party funding."

Innovation Award for Medical/Pharmaceutical Chemistry 2021

Pierre Koch
Nina Schützenmeister

The Innovation Award was awarded on the occasion of the Online FiMC 2021 to Prof. Dr. Pierre Koch and Ass.-Prof. Dr. Nina Schützenmeister awarded.

Prof. Dr. Koch: "In recognition of his excellent, original and pioneering research work. Dr. Koch developed selective kinase inhibitors that are able to penetrate the central nervous system. These kinase inhibitors represent an innovative approach to the therapy of neurodegenerative diseases such as Alzheimer's dementia and multiple sclerosis. The scientific success of this innovative research work is documented by numerous publications in respected journals."

Prof. Dr. Schützenmeister: "in recognition of her outstanding, original and pioneering research work. Dr. Schützenmeister carried out innovative work on the synthesis of biologically active natural substances. She developed new and efficient synthesis methods and used them to obtain antibacterial and antiviral natural substances and natural substance analogues. Such will be novel analogues for improving biological activity are accessible. The scientific success of this innovative and extremely independent research work is documented by publications in respected journals."

Innovation Award for Medical/Pharmaceutical Chemistry 2020

Oliver Koch
Daniel Merk

The Innovation Award 2020 was awarded to PD Dr. Oliver Koch and Mr. PD Dr. Daniel Merk forgive.

PD Dr. Oliver Koch: " in recognition of his excellent, original and pioneering research work. Dr. Koch carried out groundbreaking work on the development and application of computer-aided methods for the rational molecular design of new biologically active substances. In particular, he dealt with targets for combating mycobacterial infections and for modulation epigenetic processes. The scientific success of this innovative and extremely independent research work is documented in numerous publications in respected journals."

PD Dr. Daniel Merk: " in recognition of his excellent, original and pioneering research work. Dr. Merk carried out innovative work on the modulation of nuclear receptors. This important class of proteins offers poorly characterized, potential new targets for drug development. Dr. Merk used for his previous research work a broad spectrum of methods, which also includes computer-aided methods. In his still young scientific career, he has already achieved an astonishing number of high-quality publications."

Innovation Award for Medical/Pharmaceutical Chemistry 2019

F. von Nussbaum, A. Brunschweiger,
S. Laufer (v.l.n.r.; Foto: Dr. L. Höllein,
Universität Würzburg)

The 2019 Innovation Award was awarded at the annual conference “Frontiers in Medicinal Chemistry” to Dr. Andreas Brunschweiger awarded "in recognition of his outstanding, original and pioneering research work. Dr. Andreas Brunschweiger has developed and synthesized innovative DNA-encoded substance libraries for numerous substance classes. These libraries enable the rapid and efficient identification of new lead structures in drug research."

Innovation Award for Medical/Pharmaceutical Chemistry 1999ff

2024

Dr. Thanigaimalai Pillaiyar, Tübingen

2023 Dr. Matthias Schiedel, Erlangen-Nuremberg
2022 Dr. Steffen Pockes, Regensburg
Dr. Oliver Thorn-Seshold, Munich
2021 Dr. Pierre Koch, Regensburg
Ass.-Prof. Dr. Nina Schützenmeister, Vienna
2020 PD Dr. Oliver Koch, Münster
PD Dr. Daniel Merk, Frankfurt
2019 Dr. Andreas Brunschweiger, Dortmund
2018

Prof. Dr. Finn K. Hansen, Leipzig
Dr. Alexander Titz, Saarbrücken

2017 Prof. Dr. Anna Katharina Herta Hirsch, Saarbrücken
 
2016

Dr. Andreas Koeberle, Jena
Dr. Dennis Schade, Dortmund

2015 Dr. Nuska Tschammer, Erlangen
Dr. Peter Kolb, Marburg
2014 Jun.-Prof. Dr. Peter Wich, Mainz
2013 Dr. Johanne Notni, Munich
2012 Dr. Christian Ottman, Dortmund
2011 Jun.-Prof. Dr. Ingo Ott, Braunschweig
Dr. Andreas Bender, Cambridge, UK
2010 Dr. Daniel Rauh, Dortmund
2008 Dr. Franz von Nussbaum, Wuppertal
2007 Prof. Dr. Christoph Sotriffer, Marburg
2006 PD Dr. Andrea Sinz, Leipzig
2005 PD Dr. Eric Beitz, Tübingen
Dr. Holger Gohlke, Frankfurt
2003 PD Dr. Franz F. Paintner, Munich
2002 Dr. Jörg Rademann, Tübingen
2001 Dr. Andreas Link, Hamburg
Dr. Wolfgang Sippl, Düsseldorf
2000 Dr. Manfred Jung, Münster
1999 PD Dr. Thomas Carell, Zurich, Switzerland
Dr. Martin Schlitzer, Marburg
1998 Habilitation Prize
Dr. Joachim Jose
Dr. Tanja Schirmeister

This page has been machine translated. If you have any feedback or comments please feel free to contact us.

last modified: 01.07.2024 19:29 H from Translator